X0306
4
2019-04-09
0
0001714899
Denali Therapeutics Inc.
DNLI
0001724311
Schuth Alexander O.
C/O DENALI THERAPEUTICS INC.
151 OYSTER POINT BOULEVARD, SECOND FLOOR
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
COO and Secretary
Common Stock
15738
D
Common Stock
2019-04-09
4
S
0
2475
28.17
D
652614
I
See footnote
Common Stock
2019-04-10
4
S
0
2513
28.26
D
650101
I
See footnote
Common Stock
2019-04-11
4
S
0
2512
27.73
D
647589
I
See footnote
The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $27.82 to $28.68 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The shares are held of record by the Schuth Family Trust, for which the Reporting Person serves as trustee.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $27.86 to $28.84 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $27.46 to $28.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
/s/ Tyler Nielsen, by power of attorney
2019-04-11